Merck Sued Again for Gardasil Vaccine Adverse Events

The number of lawsuits filed in North Carolina against Merck for its HPV (human papillomavirus) vaccine, Gardasil, continue to mount and allege the company did not prove the vaccine was safe and effective before marketing it as an anti-cancer vaccine. Since 2022, almost 200 lawsuits alleging serious injury after receiving Gardasil have been consolidated in […]
CDC Investigating Reports of Illnesses from Botox Injections

According to the U.S. Centers for Disease Control and Prevention (CDC), as of Apr. 12, 2024, a total of 18 people from nine states have reported adverse reactions after receiving Botox injections from unlicensed or untrained individuals or in “non-healthcare” settings, such as homes and medi-spas. The states reporting adverse reactions to Botox include Colorado, […]
Princess Catherine is One of Many More Young Adults With Cancer
It is called early onset cancer. And the Princess of Wales, diagnosed at 42, is part of an unfortunate new trend of more and younger cancer cases. Yale, Harvard and the American Cancer Society each weighed in recently on this unthinkable twist in the toll of cancer. A record 2 million people in the United […]
Texas Man and Dairy Cattle Test Positive for Bird Flu

A man in Texas has tested positive for the H5N1 bird flu after direct exposure to infected dairy cattle. While this is the second recent case of bird flu identified in humans in the United States, it is the first time the disease has been found in dairy cattle.1 The first case of H5N1 in […]
Drinking Water Fluoridation: Is It Safe?

Experts have called the practice of adding the chemical compound fluoride to drinking water as “safe and effective” for decades. The U.S. Centers for Disease Control and Prevention (CDC) has named it one of the top 10 greatest health achievements of the 20th century. For years, those who have opposed it have been called “anti-science” […]
CDC Pushes Pfizer’s Pentavalent Meningococcal Vaccine
On Oct. 20, 2023, Pfizer, Inc. announced that the U.S. Food and Drug Administration (FDA) approved its new pentavalent meningococcal vaccine, Penbraya, which targets five meningococcal serogroups (A, B, C, W and Y) that most commonly cause meningococcal disease in adolescents and young adults 10-25 years old. Penbraya, is recommended to be given in two […]